PRESS RELEASE published on 04/04/2024 at 08:00, 5 months 16 days ago Aquis Stock Exchange: Restoration to Trading Aquis Stock Exchange announces the restoration of trading for Tectonic Gold Plc shares on the Aquis Growth Market. Contact the Regulation Department for more information Aquis Stock Exchange Aquis Growth Market Tectonic Gold Plc Restoration To Trading Regulation Department
BRIEF published on 03/28/2024 at 08:05, 5 months 23 days ago Aquis Stock Exchange Announces Withdrawal of Asimilar Group Plc Shares Shares Aquis Stock Exchange Withdrawal From Trading Asimilar Group Plc Market Changes
BRIEF published on 03/28/2024 at 08:05, 5 months 23 days ago La Bourse d'Aquis annonce le retrait des actions d'Asimilar Group Plc Actions Bourse Aquis Retrait Du Trading Groupe Asimilar Plc Changements Du Marché
PRESS RELEASE published on 03/28/2024 at 08:00, 5 months 23 days ago Aquis Stock Exchange: Withdrawal from Trading Aquis Stock Exchange announces the withdrawal of Asimilar Group Plc's ordinary shares (symbol: ASLR, ISIN: GB00BFX2VL54) from trading on 28th March 2024 Trading Aquis Stock Exchange Withdrawal Asimilar Group Plc Equity Market
BRIEF published on 03/18/2024 at 08:05, 6 months 2 days ago Aquis Stock Exchange Announces Withdrawal of PanGenomic Health Inc. from Trading Aquis Stock Exchange Withdrawal From Trading Growth Market PanGenomic Health Inc. Securities Regulation
BRIEF published on 03/18/2024 at 08:05, 6 months 2 days ago La Bourse Aquis annonce le retrait de PanGenomic Health Inc. de la négociation Bourse Aquis PanGénomique Santé Inc. Retrait Du Trading Marché En Croissance Réglementation Des Valeurs Mobilières
PRESS RELEASE published on 03/18/2024 at 08:00, 6 months 2 days ago Aquis Stock Exchange: withdrawal from trading Aquis Stock Exchange announces withdrawal of PanGenomic Health Inc. shares from trading in the Growth Market effective March 18, 2024 Trading Aquis Stock Exchange Growth Market Withdrawal PanGenomic Health Inc.
PRESS RELEASE published on 02/16/2024 at 08:00, 7 months 4 days ago Aquis Stock Exchange: withdrawal from trading Aquis Stock Exchange announces the withdrawal of Looking Glass Labs Inc. common shares (Symbol: NFTX) from trading on the Growth Market effective 16 February 2024 Aquis Stock Exchange Growth Market Withdrawal Looking Glass Labs Inc. NFTX
PRESS RELEASE published on 01/29/2024 at 08:00, 7 months 22 days ago Aquis Stock Exchange: Withdrawal from trading Aquis Stock Exchange announces the withdrawal of Western Selection PLC ordinary shares from trading on the Aquis Stock Exchange Growth Market Ordinary Shares Aquis Stock Exchange Withdrawal From Trading Western Selection PLC Growth Market
PRESS RELEASE published on 10/30/2023 at 08:00, 10 months 21 days ago Aquis Stock Exchange: Admission to Trading
Published on 09/20/2024 at 02:00, 6 hours 58 minutes ago Academy of Math and Science Celebrates Hispanic Heritage Month
Published on 09/19/2024 at 23:15, 9 hours 43 minutes ago Cypher Metaverse Inc. Announces Second Closing of Financing
Published on 09/19/2024 at 23:00, 9 hours 58 minutes ago WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Published on 09/19/2024 at 23:00, 9 hours 58 minutes ago Cerrado Files NI 43-101 Preliminary Economic Assessment Technical Report and Mineral Resource Estimate for The Minera Don Nicolas Mine in Santa Cruz, Argentina
Published on 09/20/2024 at 07:30, 1 hour 28 minutes ago XTPL with PLN 5.6 million of commercial sales in H1 2024 and progress on industrial projects - press release
Published on 09/20/2024 at 07:00, 1 hour 58 minutes ago Mister Spex SE: Extraordinary General Meeting adopts all resolutions as proposed by the Company’s Boards
Published on 09/20/2024 at 06:26, 2 hours 32 minutes ago Original-Research: www.warimpex.com (von East Value Research GmbH ):
Published on 09/20/2024 at 05:15, 3 hours 43 minutes ago Alibaba Cloud Empowers Customers and Partners with its Proven Large Models and High-Performance Infrastructure
Published on 09/20/2024 at 08:00, 58 minutes ago MEDESIS PHARMA : Résultats encourageants de la première phase de l’essai clinique de phase 2a pour le traitement de la maladie d’Alzheimer avec le NanoLIthium